What does bespoke assay development achieve?

Bespoke assay development enables precise investigation of specific biological questions by tailoring assay design to defined targets, pathways, or disease models.

Why not use standard assays?

Standard assays may not capture the complexity or specificity required for certain studies. Customised assays improve signal relevance and reduce the risk of misleading results.

How does this approach support osteoarthritis research?

In osteoarthritis, bespoke assays can be designed to monitor cartilage degradation, inflammatory signalling, and matrix remodelling, providing targeted insights into disease progression; at Cellomatics, this is achieved using primary human cell systems, disease-relevant in vitro models, and customised assay workflows aligned to specific therapeutic mechanisms.

What defines a strong assay development strategy?

A successful strategy aligns assay design with the biological question, selecting appropriate models, readouts, and controls to capture meaningful changes.

How is the right model selected?

Model selection depends on disease context, cell type, and experimental goals. Cellomatics uses human-relevant systems, including primary cells and co-cultures, to ensure physiological relevance.

How does bespoke assay development improve data quality?

By focusing on biologically meaningful endpoints, customised assays reduce background noise and enhance interpretability, leading to more robust conclusions.

Cellomatics named winner of Judges’ Award

Cellomatics has been chosen as the winner of the Judges Award at the Medilink Midlands Business Awards 2026.

On Thursday 23 April, Cellomatics attended the Medilink Midlands Business Awards 2026, held at the Empire Banqueting Hall in Leicester. Cellomatics was selected for the prestigious Judges Award, an award decided by the judges for businesses which show a great deal of potential.

The team were delighted to be presented with this award, with Cellomatics CEO and Founder Shailendra Singh saying “This is a great achievement and a strong recognition of the work we are all doing together. It reflects the effort, dedication, and commitment across the entire team and I could not be more proud of the work that has gone into this”.

The Medilink Midlands Business Awards bring together industry leaders, innovators, and collaborators from across the region as the annual awards recognise the organisations and individuals driving forward innovation, improving patient outcomes, and delivering real-world impact across the life sciences sector.

The entire Cellomatics team are thrilled to have been chosen for this award and enjoyed celebrating the win together!

Keep an eye out for any further award wins and shortlists on our news page.

April 27, 2026
5:09 pm

Request a consultation with Cellomatics Biosciences today

Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke project plan with a professional, flexible service and a fast turnaround time.

To request a consultation where we can discuss your exact requirements, please contact Cellomatics Biosciences.